United States
![Center for Reproductive Rights logo](https://reproductiverights.org/wp-content/uploads/2021/05/square-logo-709x422.jpg)
Leading Reproductive Health, Rights, and Justice Organizations Launch ‘Abortion Access Now’ Campaign and $100 Million Investment
06.24.24 (PRESS RELEASE) – Marking the two-year anniversary of the Dobbs decision, leading reproductive health, rights, and justice organizations have launched the ‘Abortion Access Now’ campaign, pledging a $100 million investment to advance abortion rights and access across the United States. The funding will help build a long-term federal strategy to codify the right to […]
Texas Medical Board Fails to Clarify Abortion Ban Exceptions
6.21.2024 (PRESS STATEMENT) — Today, the Texas Medical Board published rules to purportedly clarify exceptions to the state’s harsh abortion bans. The rules were published after undergoing a 30-day public comment period and a public hearing, during which numerous physicians and concerned citizens– including Kate Cox and multiple plaintiffs in Zurawski v. Texas – spoke […]
![Rally at south carolina legislature](https://reproductiverights.org/wp-content/uploads/2022/12/Rally-South-Carolina-State-Legislature-cropped-750x422.jpeg)
Abortion on the Ballot
Since the U.S. Supreme Court eliminated the constitutional right to abortion, voters have come out and shown strong support for reproductive freedom. Voters in more states will get to weigh in this November.
![virtual town hall](https://reproductiverights.org/wp-content/uploads/2023/06/DobbsAnni_LandingPage_TownHall-04-1-750x422.png)
Join us! Virtual Town Hall on U.S. Abortion Rights: Thursday, June 20
“Protecting Rights: Updates on the Fight for Abortion” provides a valuable update on cases at the U.S. Supreme Court and in the states, state ballot initiatives to protect abortion rights, and more.
![medication abortion](https://reproductiverights.org/wp-content/uploads/2023/03/lightbox-abortion-medication-750x422.jpg)
Access to Abortion Medication Remains Unchanged After Ruling by the U.S. Supreme Court
Court rules that anti-abortion plaintiffs suing the FDA do not have standing, leaving the widely used abortion drug accessible through telemedicine and pharmacies—for now.
![Center for Reproductive Rights logo](https://reproductiverights.org/wp-content/uploads/2021/05/square-logo-709x422.jpg)
Supreme Court Ruling Maintains Access to Mifepristone
Current regulations of mifepristone will remain unchanged for now
![Center for Reproductive Rights logo](https://reproductiverights.org/wp-content/uploads/2021/05/square-logo-709x422.jpg)
U.S. Supreme Court Ruling: Alliance for Hippocratic Medicine v. FDA
![Amanda Zurawski Molly Duane instagram reels 2](https://reproductiverights.org/wp-content/uploads/2024/06/Amanda-Zurawski-Molly-Duane-instagram-reels-2-750x422.png)
Reactions to the Zurawski Ruling: Molly Duane and Amanda Zurawski
“Frankly, this ruling feels like a gut punch, not just for pregnant Texans but also for doctors in our state.” —Lead plaintiff Amanda Zurawski
![Building exterior of the U.S. Department of Health and Human Services in Washington, D.C.](https://reproductiverights.org/wp-content/uploads/2021/02/02232021_LP_Admin-Advocacy_HHS_1379742251-huge-750x422.jpg)
Comments Submitted to U.S. Federal Agencies
Recent comments submitted by the Center’s U.S. Federal Policy and Advocacy team on proposed rules and regulations impacting reproductive health and rights.